Epidem-1#1

    ก

%&' ()* + ,-../ 0 %)* ก &' (+   02?
 :     E-Mail: [email protected]

%&' ()* + -4ก5ก676ก (8 ,)0  --> 8 4ก&' ()* ก:., 0 &' ()* , 4ก&' ()*

%)* ก &' (+ -4ก5ก676* 0)7 ก --> )7 , 4ก/, ):<ก ) 4

=&8 =ก   )7 4903502 )* ก &' (=&4กก D'D-ED (Epidemiology and Principles of Disease Control) D40R-R0 “7 R'” ( -S กก ) 6)7 )* ก &' (=&4กก D'D-ED URL: http://www.esnips.com/web/EPIDEM-1

1

R',R/,.[ R0 ก ,< *<\ 1 (L-1) -->
   !"#$%  ก
-->  $ ก&'ก&'ก(
ก&' !
 ก ก !$)*%
!  ก
--> (  ! +&ก),ก- ก "  .


1-1
   ! "#$% ก
"( )*%(*(") ก --> ก(, 

$( "2 40 "5&'6& !ก( ก7&
"8 !   460 "5 ก
.). Hippocrates "$E%$ก&ก + กก #
FF ก กG!,ก!(&'$ ' ก(   !&
*((+%ก( * ' ! . (  $)-&' 16 Fracastoro %$ !& + *#

 $ #
!I*ก(F 3 
 ก
*
 กก) !# 6(I(ก!

1-1
   ! "#$% ก

1-1
   ! "#$% ก


"( )*%(*(") ก --> ()


"( )*%(*(") ก --> ()


.).1747 James Lind F),ก-*กก #
Scurvy # *(ก ก!ก  ! Citric Acid W6!F(ก-#
& F $&(กX(6!ก),ก- !W GF"!   
.).1769 Baker F),ก-ก Colic (ก * Acute lead intoxication) F"8*W
&' ' G "^_!  G "^!_ &`"8ก a,'GW*ก('!!ก 
.).1848 John Snow %$(กX- F*(ก !$  I Golden Square &' London "g"8 ก#
 ' Plot !W 6&' ! กก(W ! &' #ก&'ก("i_  G&'& 3 ( *" F&(,'&'"8(#


=
*<\(4[0,()-R0 John Snow =(0ก-R0
S_ ) /กED 670) /กED &' (6( ,-.\S` D.a. 1854

2

1-1
   ! "#$% ก
"( )*%(*(") ก --> ()


.).1854 John Snow ก7F*(กก ก#
&'ก , &ก
(  
& F"ก&'ก( -(* G"" 2  -( !*I*"F " 2ก""l_ G&' กก(W !&' -(FG"8  G"" ก7GWกก #
กก( (*(( (F&ก(ก$ 

 ก#
ก ก Vibrio Cholerae) 
.).1954 Salk Vaccine filed trail FGก! Vaccine "pก(#"! # W7ก(ก&ก !
 *G7

1-1
   ! "#$% ก

 ก (Epidemiology) --> ,Sc)7 ก *<\

adกe 4กef&ก ,ก)( ก ก& R0ED =&g4 Rg  6S&7 ก -e -5d0ก D  ,/=&Sh

4 ก8 (*<\-<)*:)*8 6,ก)( =&=ก& Rd[ – epi --> on, upon -->  – demos --> people, human population --> "$$ ("$ก-%) – logy --> the study of, knowledge --> ก),ก-,
, )*%

40-< &,< (*<\ 6 *<\2(*2S<ก- ก /)(/ -/2(*<\ http://th.wikipedia.org/wiki/&' ()*

1-1
   ! "#$% ก
 ก --> )* ก &' (2-67 R )7

(Discipline) =/,Sc,D.\0-. (Tools) *<\676ก adกe Shj  : fR . ก adกe )* ก &' ( D.ก adกe ,.\* '5d0):ก<  (Methodology) 6 ก adกe ED=&Shj * 0ก =* =& : fR E( SD.ก adกe *<\ D'D-S&,(k8 D4j/ 0 l (40<[  กก#
(Distribution), "i( (กG&'& + !ก ก#
 กก #
(Determinant), "$ก-% (Human population), ก"!&' "!#
(Dynamic), `&'"8#
!FW$ #
(Disease and non-disease conditions), #
 $  !#
F$  (Infections and non-infections disease) ! ก"pก( !

 (Prevention and control)

1-1
   ! "#$% ก
 ก --> ()
What is infectious disease epidemiology?

A case is a risk factor w Infection in one person can be transmitted to others

3




 ก --> () – Endemic (EDS& 8 5)\): Refers to a disease or infection that is particular to a particular group of people for a very long time period. Endemic refers to a disease that is normally occurring in a population. – Epidemic (ED&' (): Refers to an increase in a particular disease or infection in a group of people over what is normally occurring in the particular population. – Pandemic (ED&' (*4\Eก): Refers to an increase of a particular disease or infection over what is normally occurring in the worldwide population.

1-1
   ! "#$% ก
 ก -->

 ,.\* 'R (=&ก ก& R0ED=&g4 Rg  67-7 6 -)/)*<\,ก<\ ก4' 'DD (Person) , (Time) =&5 *<\ (Place)  ,.\* ' ,/R0ED=&g4 Rg   ,.\* ':-7 /)R0ก ,ก)(ED=&g4 Rg  Sh

4 ก8 (*<\-< )*:) =&):<ก 5 *(ED  ,.\67,Sc=* 06ก  0=
ก D'D-=&So0ก4ก ,ก)( ED=&g4 Rg  *4[06Sh

'4=&6 D/

1-1
   ! "#$% ก
 ก --> ()

Number of Cases of a Disease

1-1
   ! "#$% ก

Endemic

Epidemic

Time

1-1
   ! "#$% ก
 ก --> =0 R,*k

)0 R-*<\

5ก/0 E( 67):<ก '- ,< ',< 0 ),D & =SD -- =& 8 ,R- ,.\S&,-)g *<\*8 62(D8 /'6ก S4'S0=& 4p 0  : fR )* ก &' ( &7 'ก5d0ED =&g4 Rg *<\,ก)(Rd[  -
4

1-1
   ! "#$% ก
"#$% ก --> ก 

1-1
   ! "#$% ก
"#$% ก -->  $ก

 7 adกe (ก ,S<\ =S0R0ก ,ก)( ก ก& =&=ER0ก ,ก)(ED  67,Sc=* 06ก 6')ก  : fR*4[0* 0( ก 0,)Rg  ก D'D-So0ก4ED ก 4กe  '  =&ก rstr g ( Rg   67,Sc=* 06ก adกe ) 4 =&D  ,/*<\=* )0R0 Shj ก ,ก)(ED =&g4 Rg  ,.\'ก):<ก =ก2R  0-< S&)*:)g 

 7 D =& 4(8 (4'D -8 D4jR0Shj  7 6* '/,/=&Sh

4 *<\,ก<\ ก4'Shj  : fR4[ l  7 6ก D)(D./4()6 6ก 67- /ก *<\ &So0ก4=& D'D-EDE( *<\- /ก 4[D &-
1-2  $ ก
ก&' !
 กก($)*%
!  ก


 $ ก --> 2 "`
  )* ก &' (: Classical (Traditional) epidemiology - 5d0 ก 67)* ก &' (*<\ d(S&7 7.7-7,Sc4ก =&,Sc ก adกe Shj R0ED/g4 Rg  67-7ud\0-0,6ก D Sh

4 ,<\ 0 (Risk Factor) *<\ &8 2Sก So0ก4=&-<ก ,< ก<ก 7.\ %Public Health Epidemiology+  ,7a / D))ก: Clinical epidemiology - 5d0 ก 67)* ก  &' (*<\ d(5 ')ก  : fR,Sc4ก E( -<4/5S&0D ,.\4p ก /4()6 6ก 4กe
S_ *4[06=0ก )) x4 ก  4กe =&ก  กf ED

1-2  $ ก
ก&' !
 กก($)*%
!  ก


 $ ก --> ()  . F&ก$  &' ()* ,7)040D- (Social epidemiology) - 5d0 ก adกe g &Rg *<\,ก<\ R0ก4')\0=(-/ 0 l =&* 040D &' ()* Eg7 a / (Nutritional epidemiology) - 5d0 ก adกe )* ก &' (*<\,ก<\ ก4'g &Eg7 ก   ...

5

1-2  $ ก
ก&' !
 กก($)*%
!  ก


 $ ก --> ()  $&'ก&' $  ,7a / D))ก (Clinical medicine)   :))* (Pathology)  7<)* (Microbiology)  S  )/)* (Parasitology)  7<5)/) (Biostatistics)  S&7 กa / (Demography)  .\ l ,7 ,7a / 74 / 40<)* ...

1-3 (  ! +&ก),ก- ก "  .


!(กก&'W$Wก),ก- ก --> &' 2
  ก ,ก)(ED (Disease occurrence) S&ก'( D (Host) /4กED (Agent) =&)\0=(- (Environment)  ก ก& R0ED (Disease distribution) S&ก'( , (Time) 5 *<\ (Place) =&4กef&'DDR0
S _ (Person)  )\0ก8 ( (Determinant) D.Sh

4 *<\*8 6,ก)(ก ก& R0ED-<ก  ,S<\ =S02S  S&7 ก - 5d0D -,Sc7-7 . &,S< ',*< 'ก4กk/0S4'6q  ,Scq ,(< ก4 ,7ก 674/ S_ . 4/ S_ / ,x &ED ,Sc/

1-2  $ ก
ก&' !
 กก($)*%
!  ก



ก&' !
 กก(z --> "7

 ก

$)*%
!  ก

"$ก&'ก&'

"$กW$$( 

6"g}&'( ก



),ก-กก#
W$$ ก * ** กก"pก( !

#
(ก 

),ก-ก  }( !ก(ก-#


1 : many

1:1

G"$ก&'F7"g

G6"g&' (ก- !

 '
*((+% (ก $$&"$ก ก2{%&'W$(
*G7

6"g&'( ก

1-3 (  ! +&ก),ก- ก "  .
 +&ก),ก- ก --> & 3 "


  )* ก &' (,7)0f (Descriptive epidemiology)  )* ก &' (,7)0),D & (Analysis epidemiology) ก adกe 2SR 0 (Prospective Study) ก adกe 40 (Retrospective Study) ก adกe f (, 6(, d\0 (Cross-sectional Study)

 )* ก &' (,7)0*(0 (Experimental epidemiology)

6

1-3 (  ! +&ก),ก- ก "  .
 +&ก),ก- ก --> ()

 )* ก &' (,7)0f (Descriptive epidemiology)

1-3 (  ! +&ก),ก- ก "  .
 +&ก),ก- ก --> ()

 )* ก &' (,7)0),D & (Analysis epidemiology)

adกe  ED&2 (what) ,ก)(ก4'6D (who) *<\2 (where) =&,ก)( ,-.\2 (when) ,.\67 4(8 (4'D -8 D4j --> PDCA D.  0=
So0ก4=&D'DED& &/ 0 l --> (8 ,)ก =ก2RShj --> S&,-)
 --> S4'6- .*8 u[8 ก adกe S=''<[ 8 ,Sc/0-
,ScR4[/ ก)* ก &' (,7)0f ,.\/'D8 5 -/ ,ก)(Rd[ 2(  02 (How) E( ,2S*<\ก adกe  D -4-4: R0Sh

4 *<\ ,Sc ,/R0ED/g4 Rg  ud\0

&/0-<ก 8  7-7 ก  'ก &' ( .ก ) 4 * 0)* ก &' (,Sc,D.\0-. (8 ,)ก  ='0  2(,Sc...

1-3 (  ! +&ก),ก- ก "  .

1-3 (  ! +&ก),ก- ก "  .


 +&ก),ก- ก --> ()

 )* ก &' (,7)0),D & (Analysis epidemiology) (/) ก adกe 2SR 0 (Prospective Study) ,Scก ,S< ',*< ''4/)ก f 6,.\0,/ Sh

4 ,<\ 0 =&ก-*<\2-2(4-
4 ก adกe 40 (Retrospective Study) ,Scก adกe ก4'2S  ,/.Sh

4 ,<\ 0/ก ,ScED ก adกe f (, 6(, d\0 (Cross-sectional Study) ,Scก adกe ,.\:)' 5d0D -4-4: R00D S&ก'/ 0 l ก4'ED


 +&ก),ก- ก --> ()

 )* ก &' (,7)0*(0 (Experimental epidemiology) • ,Scก adกe E( 67S=''ก *(0* 0D))ก .ก *(06 7-7 ,.\ D -4-4: R0Sh

4  ,/ ,7 ก *(0
R0 4Du<So0ก4ED .- /ก /):<ก So0ก4ED/ 0 l • 4กก 8 D4jD. 4ก Max Min Con 2(=ก ...

7

1-3 (  ! +&ก),ก- ก "  .




 +&ก),ก- ก --> ()

 )* ก &' (,7)0*(0 (Experimental epidemiology) (/)

– Maximized systematic variance - 5d0 ก *8 6D D -=SS

& 0ก-*(0-
1-3 (  ! +&ก),ก- ก "  .


กG  ก --> 3 !(ก-2


 ก ,~o &40* 0)* ก &' ( (Epidemiological Surveillance)

,Scก) ก-6ก /)(/ -'-R-ก ,ก)(ED /(, ,.\* ' D -,S<\ =S0 --> 0.506

 ก '* 0)* ก &' ( (Epidemiological Investigation) ,Scก D R,*k

)06กf<,ก)(Shj ก &' (R0EDRd[ 
S_  <[,ScED&2 D ( 2S4-
4ED ก6D )\06( ,ก)(EDRd[2(  02 =& &7 6ก  0=
 &D'D-So0ก4ED2(  02  ก adกe * 0)* ก &' ( (Epidemiological Studies) ,Scก  (8 ,)ก ,.\6* ' &,< (R0Shj 64กef&/ 0 l - กRd[

8